Avant Fine Chemicals Ltd. is a chemical-pharmaceutical company that is exclusively dedicated to the production of synthetic Active Pharmaceutical Ingredients (APIs) in accordance with Current Good Manufacturing Practices (cGMP) to ensure that their products have reproducible quality and comply with pre-established specifications.
It is responsible for controlling that raw materials, intermediates, final products, auxiliary materials and packaging in compliance with WHO current GMP.
Analytical methods and specifications are both developed and validated by an experienced professional team.
Reference Standards are also characterized and supplied.
Stability studies, in-process controls and equipment cleaning validation are performed in this Division.
The Impurity Profile of each API developed at Avant is carefully studied (including Residual Solvents, Genotoxic Impurities, Residual Catalysis and Polymorphism).
All these studies are carried out employing advanced techniques to conform to international requirements (ICH Guideline and Pharmacopoeias).
Equipment for physicochemical characterization of powders: Sieve Shaker Systems, Tap Density Tester, Microscopes and Malvern (PSD) System will be installed to make QC compliance with WHO GMP.
The Validation Master Plan includes Process and Cleaning Validation, which is performed in accordance with FDA, ICH regulatory guideline.
Both internal and external inspections are regularly carried out.
Inspection from Health Authorities and customers are periodically received.
Documentation from the starting of the plan thinking till the product launching will be kept as per the guideline of FDA and ICH.